Monaco cosmetic actives maker Exsymol is collaborating with ExAdEx-Innov, a University of Nice biotechnology startup, to maximize the value of its ingredients.
ExAdEx-Innov has over three decades of experience in research on human adipose tissue to offer innovative tools for the cosmetic, nutraceutical and biomedical industries.
ExAdEx technology exploits the intrinsic ability of adipose stem cells to proliferate in response to stimuli and uses the native tissue matrix as a bioactive support for their proliferation.
These ex vivo models have unique characteristics, including long-term viability, a complete extracellular matrix structure, lipid droplet size comparable to endogenous tissue and more.
“The ExAdEx technology offers a unique opportunity for innovation in research and product development in the field of adipose tissue. Working in partnership opens up new possibilities in the beauty industry,” said an Exsymol spokeswoman.
“This collaboration marks a significant step in the repositioning and development of cosmetic assets, using high-quality ex vivo human adipose tissue models that closely resemble in vivo tissue to assess new claims and generate relevant data,” she added.